Display options
Share it on

Can Med Assoc J. 1977 Mar 19;116(6):645-8.

Hemodynamic and therapeutic effects of intravenous dopamine.

Canadian Medical Association journal

P Théroux, H F Mizgala, M G Bourassa

PMID: 608165 PMCID: PMC1879175
Free PMC Article

Abstract

The effects of intravenous dopamine were evaluated in 10 patients with severe but stable coronary artery disease, 17 consecutive patients with primary cardiogenic shock and 3 with severe congestive heart failure and oliguria. Dopamine infusion at 10 mug/kg.min in the 10 patients increased cardiac output by 35%, left ventricular peak dP/dt by 38%, left ventricular minute work index by 44% and mean systolic ejection rate by 7% (P < 0.01); heart rate, aortic pressure, left ventricular end-diastolic pressure and tension-time index were unchanged. For oxygen, potassium and lactate, arterial and coronary sinus values, coronary arteriovenous oxygen differences and myocardial extraction were unchanged. Hemodynamically 13 of the 17 patients in shock responded favourably to dopamine infusion (0.5 to 15 mug/kg.min), with decrease in heart rate, increase in systolic arterial pressure from 75 to 100 mm Hg (P <0.001), decrease in ventricular filling pressure from 20 to 16 mm Hg (P < 0.01) and increase in urine output from 10 to 100 ml/h (P < 0.01). Eleven of those patients survived the shock episode. A close relation was observed between the hemodynamic response to dopamine, survival from the shock episode and the time between onset of shock and initiation of therapy. Low rates of dopamine infusion induced diuresis in the three patients with severe cardiac failure.Dopamine thus seems to improve the mechanical efficiency of the heart in coronary artery disease. Cardiac output is selectively increased and myocardial ischemia does not appear to be induced; those beneficial effects as well as presumably specific action on renal flow and natriuresis, improve immediate survival from cardiogenic shock and severe heart failure.

Similar articles

Cited by

References

  1. J Pharmacol Exp Ther. 1964 Jul;145:64-70 - PubMed
  2. J Clin Invest. 1964 Jun;43:1116-24 - PubMed
  3. N Engl J Med. 1963 Nov 14;269:1060-4 - PubMed
  4. J Pharmacol Exp Ther. 1963 Nov;142:157-62 - PubMed
  5. Circ Res. 1962 Feb;10:237-43 - PubMed
  6. Am Heart J. 1968 Feb;75(2):233-9 - PubMed
  7. Am Heart J. 1972 Jun;83(6):743-8 - PubMed
  8. Am Heart J. 1974 May;87(5):550-7 - PubMed
  9. Cardiovasc Res. 1973 Jul;7(4):438-45 - PubMed
  10. Circulation. 1971 Aug;44(2):163-73 - PubMed
  11. Rev Med Liege. 1970 Mar 15;25(6):173-81 - PubMed
  12. Am J Physiol. 1969 Dec;217(6):1716-20 - PubMed
  13. Circulation. 1969 Mar;39(3):361-78 - PubMed
  14. N Engl J Med. 1966 Dec 22;275(25):1389-98 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources